厦门特宝生物工程股份有限公司2026年第一次临时股东会决议公告

Core Viewpoint - The company held its first extraordinary general meeting of shareholders in 2026, where all proposed resolutions were approved without any objections from shareholders [2][9]. Group 1: Meeting Details - The meeting took place on February 11, 2026, at the company's conference room located at 330 Wengjiao Road, Haicang New Industrial Zone, Xiamen [2]. - The meeting was convened by the board of directors and chaired by Mr. Sun Li, the chairman [2]. - The voting method combined on-site and online voting, complying with the Company Law and the company's articles of association [2]. Group 2: Attendance - All 9 current directors attended the meeting, along with the company secretary Ms. Yang Yiling and some senior management personnel [3]. Group 3: Resolutions Reviewed - The following resolutions were passed: - Approval for the company to issue convertible bonds to unspecified investors [4]. - Approval of the bond issuance plan, including types of securities, issuance scale, face value, issuance price, bond term, interest rate, repayment terms, conversion period, and pricing adjustments [4][5][6][7]. - Approval of the use of raised funds, management of funds, and related guarantees [7]. - Approval of the feasibility analysis report for the use of raised funds and the dilution of immediate returns with measures to compensate [8]. - Approval of the company's dividend return plan for the next three years (2026-2028) [8]. - Authorization for the board of directors to handle all matters related to the issuance of convertible bonds [8]. Group 4: Voting and Legal Verification - All resolutions were special resolutions and were passed with more than two-thirds of the voting rights held by attending shareholders [9]. - The meeting was witnessed by lawyers from Shanghai Jintiancheng (Shenzhen) Law Firm, who confirmed that the meeting complied with legal and procedural requirements [9].